French national register coronary angiography and coronary angioplasty
3rd edition from September 25-27, 2024 / Palais des congrès / Porte Maillot / Paris
Grouping of 11 national registers to compare our results
and initiate randomized studies on a European scale
Disease of the arteries of the heart (called coronary) affects 1.5 million people in France. It is the leading cause of mortality from all causes and myocardial infarction is responsible for 12,000 deaths/year in France.
Its management is a real public health issue.
Coronary angiography (or coronary angiography) is a test that allows you to visualize the heart or coronary arteries and treat them at the same time with an intervention called coronary angioplasty.
France PCI (Percutaneous Coronary Intervention) is a national registry of interventional cardiology which aims to identify coronary angiography and coronary angioplasty activities in France.
It is worn by:
- The GACI (Atheroma and Interventional Cardiology Group) representing French coronary angiographers to the French Society of Cardiology
- The France PCI association, promoter of the project, made up of a steering committee and a scientific committee, an ARC team, as well as investigative teams from each participating center.
- The Cardiology Clinical Research Unit of Chartres hospitals
The main objective of the registry is to improve the prognosis of coronary patients.
Indeed, cardiovascular disease is the leading cause of death in the world and its medical treatment is a real public health issue.
In France, coronary heart disease affects 1.5 million people and is responsible for 150,000 deaths each year, or one every 4 minutes. Only a perfect knowledge of the epidemiological and clinical data of patients and medical practices in interventional cardiology will allow everyone to evaluate themselves, compare themselves and, ultimately, improve their practices. The experiences of Swedish registers have demonstrated that they not only make it possible to improve the quality of the treatments provided, improve the prognosis of patients while achieving significant health savings.
Another objective is to offer the interventional cardiology community a national and exhaustive database allowing the consideration of a large number of scientific and epidemiological studies.
A total of 150 variables per procedure are integrated into the database, bringing together epidemiological, clinical and procedural data (coronarography and coronary angioplasty). Pre-hospital data in the STEMI are also analyzed (treatment times, patient journey).
Data extraction is done using reporting software (Cardioreport, Hémolia, Atout Coeur, etc.) and monitoring carried out on site by a dedicated Clinical Studies Technician recording hospital events but also morbidity. -mortality at 1 year as well as ongoing drug treatments.
The collected and anonymized data which are extracted from the professional software are transferred to an electronic database (eFrancePCI), updated daily, which makes it possible to follow over 1 year all the patients who have benefited from a coronary angioplasty or/and who have presented a myocardial infarction.